Another study reported impaired trafficking and reduced enzymatic activity in three missense GALC mutations.22 This study identified α-lobeline as a promising PCT candidate for the hyperglycosylation mutant D528N; however this compound was ineffective with other tested Krabbe disease mutations. This evidence concerns the gene GALC and Krabbe disease.